Neville Rodie & Shaw’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,054
Closed -$144K 262
2021
Q2
$144K Sell
10,054
-1,350
-12% -$19.5K 0.01% 257
2021
Q1
$160K Sell
11,404
-2,317
-17% -$37.8K 0.01% 250
2020
Q4
$257K Buy
+13,721
New +$224K 0.02% 220

Other funds holding VTRS

Neville Rodie & Shaw's VTRS Position: Q3 2021 in Review

Neville Rodie & Shaw sold out of Viatris (VTRS) in Q3 2021, closing a stake of 10,054 shares — an estimated $144K sold.

Neville Rodie & Shaw first reported a position in VTRS in Q4 2020 and held it in 3 quarters. The position peaked at $257K in Q4 2020. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q3 2021.

  • Neville Rodie & Shaw reported no remaining Viatris position as of Q3 2021 after selling out during the quarter.
  • Neville Rodie & Shaw sold 10,054 Viatris shares in Q3 2021, an estimated $144K.
  • Neville Rodie & Shaw first reported a position in Viatris in Q4 2020 and held it in 3 quarters.
  • Neville Rodie & Shaw's Viatris position peaked at $257K in Q4 2020.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q3 2021.

Based on Neville Rodie & Shaw's 13F filing for Q3 2021, filed 6 Oct 2021.